Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TRENT-ICU Study (Transfusion Threshold Based on Hemoglobin Trends): Hemoglobin Drop Rate as a Predictor of Adverse Clinical Outcomes in Critically Ill Patients

NCT07761832 is registered in ClinicalTrials.gov with Hospital H+ Queretaro as lead sponsor.

NCT NCT07761832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07761832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TRENT-ICU Study (Transfusion Threshold Based on Hemoglobin Trends): Hemoglobin Drop Rate as a Predictor of Adverse Clinical Outcomes in Critically Ill Patients
Lead sponsor
Hospital H+ Queretaro
Phase
Observational
Overall status
Completed
Start date
July 31, 2026
Completion date
July 31, 2026
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, critical illness